Deoxynucleoside can reverse the metabolism of transcriptase inhibitors in perfused heart and isolated mitochondria (37), and had the therapeutic efficacy for Tk2 deficiency (38). This evidence concerns the gene TK2 and hyperinsulinemic hypoglycemia, familial, 4.